6RL

2-[[6-[(3~{R})-3-azanylpiperidin-1-yl]-3-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]methyl]-4-fluoranyl-benzenecarboni trile

Created:	2016-06-06
Last modified:	2020-06-05

Find Related PDB Entry
1 entries where 6RL is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	46
Chiral Atom Count	1
Bond Count	48
Aromatic Bond Count	6

2D diagram of 6RL

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-[[6-[(3~{R})-3-azanylpiperidin-1-yl]-3-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]methyl]-4-fluoranyl-benzenecarboni trile
Synonyms	SYR-472
Systematic Name (OpenEye OEToolkits)	2-[[6-[(3~{R})-3-azanylpiperidin-1-yl]-3-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]methyl]-4-fluoranyl-benzenecarbonitrile
Formula	C₁₈ H₂₀ F N₅ O₂
Molecular Weight	357.382
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CN1C(=O)C=C(N2CCC[CH](N)C2)N(Cc3cc(F)ccc3C#N)C1=O
SMILES	OpenEye OEToolkits	2.0.5	CN1C(=O)C=C(N(C1=O)Cc2cc(ccc2C#N)F)N3CCCC(C3)N
Canonical SMILES	CACTVS	3.385	CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(Cc3cc(F)ccc3C#N)C1=O
Canonical SMILES	OpenEye OEToolkits	2.0.5	CN1C(=O)C=C(N(C1=O)Cc2cc(ccc2C#N)F)N3CCC[C@H](C3)N
InChI	InChI	1.03	InChI=1S/C18H20FN5O2/c1-22-17(25)8-16(23-6-2-3-15(21)11-23)24(18(22)26)10-13-7-14(19)5-4-12(13)9-20/h4-5,7-8,15H,2-3,6,10-11,21H2,1H3/t15-/m1/s1
InChIKey	InChI	1.03	IWYJYHUNXVAVAA-OAHLLOKOSA-N

Drug Info: DrugBank

DrugBank ID	DB15323
Name	Trelagliptin
Groups	investigational
Description	Trelagliptin is under investigation in clinical trial NCT03555591 (Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus").
Synonyms	Trelagliptin
Categories	Pyrimidines Pyrimidinones
CAS number	865759-25-7

Related Resource References

Resource Name	Reference
Pharos	CHEMBL1650443
PubChem	15983988
ChEMBL	CHEMBL1650443
ChEBI	CHEBI:134715

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.